ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Mezzion Pharma Co.Ltd (140410.KQ)
Mezzion Pharma Co.Ltd stock price today, ATLAS forecast and fair value
Healthcare · Pharmaceuticals · KOSDAQ · South Korea
₩53,900▼ -2.00%
Prices as of Oct 27, 2026 · KRW
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Mezzion Pharma Co.Ltd in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Mezzion Pharma Co.Ltd
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Mezzion Pharma Co.Ltd a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩46,079 and ₩60,538; in 9 out of 10, between ₩36,177 and ₩77,107. Estimated annual volatility is 83%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- ₩179,900
- 52-week low
- ₩45,850
- Revenue (12 months)
- ₩30.2B
- Gross margin
- 12.2%
- Operating margin
- -69.3%
- Net margin
- -81.7%
- Beta
- 0.76
What this means
ATLAS does not publish a fair value for 140410.KQ right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 140410.KQ has traded between ₩45,850 and ₩179,900. Today it is 70.0% below that high and 18% above its low.
Its beta is 0.76: it tends to move less than the market.
About the company
Mezzion Pharma Co.,Ltd. engages in the development, licensing, and commercialization of drugs for the treatment of vascular diseases.
Want to see everything about Mezzion Pharma Co.Ltd?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Mezzion Pharma Co.Ltd do?
Mezzion Pharma Co.,Ltd. engages in the development, licensing, and commercialization of drugs for the treatment of vascular diseases.
What is the chance 140410.KQ goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, 140410.KQ ends the month between ₩46,079 and ₩60,538.
How volatile is 140410.KQ?
ATLAS estimates annual volatility at 83%. In a typical month, half of the outcomes end between ₩46,079 and ₩60,538.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer